1. 1012No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry. (19th March 2018) Authors: Jilek, C; Brachmann, J; Lewalter, T; Kuck, K H; Andresen, D; Willems, S; Spitzer, S G; Straube, F; Schumacher, B; Eckardt, L; Danilovic, D; Thomas, D; Hochadel, M; Senges, J Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1075Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more. Data from the German Device Registry. (19th March 2018) Authors: Bogossian, H; Hochadel, M; Ince, H; Spitzer, S G; Eckardt, L; Maier, S; Kleemann, T; Brachmann, J; Stellbrink, C; Gonska, B D; Kaab, S; Senges, J; Lemke, B Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1272Effect of age, genetic background and experimental conditions on left atrial monophasic action potential duration, effective refractory period and activation time in Langendorff-perfused murine hearts. (18th June 2020) Authors: Obergassel, J; Kabir, S N; O"reilly, M; Sommerfeld, L C; O"shea, C; Eckardt, L; Kirchhof, P; Fabritz, L Journal: Europace Issue: Volume 22(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 366No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure - results from German Ablation registry. (28th August 2018) Authors: Jilek, C; Brachmann, J; Lewalter, T H; Kuck, K H; Andresen, D; Willems, S G; Spitzer, S G; Straube, F; Schumacher, B; Eckardt, L; Danilovic, D; Thomas, D; Hochadel, M; Senges, J Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality – insights from the German Ablation Registry. (14th October 2021) Authors: Schleberger, R; Metzner, A; Kuck, K H; Andresen, D; Willems, S; Hoffmann, E; Deneke, T; Eckardt, L; Brachmann, J; Hochadel, M; Senges, J; Rillig, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antiarrhythmic effect of ranolazine in combination with selective NCX-inhibition in an experimental model of atrial fibrillation. (25th November 2020) Authors: Wolfes, J; Ellermann, C; Broer, N; Willy, K; Rath, B; Leitz, P; Wasmer, K; Eckardt, L; Frommeyer, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Approach to wide complex tachycardias in patients without structural heart disease. Issue 5 (13th April 2006) Authors: Eckardt, L; Breithardt, G; Kirchhof, P Journal: Heart Issue: Volume 92:Issue 5(2006) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atrioventricular nodal re-entrant tachycardia in a patient with Ebstein anomaly. Issue 9 (13th August 2004) Authors: Mönnig, G; Wasmer, K; Eckardt, L Journal: Heart Issue: Volume 90:Issue 9(2004) Page Start: e58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes. (25th November 2020) Authors: Frommeyer, G; Dimanski, D; Ellermann, C; Wolfes, J; Eckardt, L Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model. (3rd October 2022) Authors: Frommeyer, G; Uphoff, J; Wolfes, J; Eckardt, L; Ellermann, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗